Dan Rozenfeld

Dan Rozenfeld is a Principal in Private Equity at The Blackstone Group, a position held since July 2018. In addition to this role, Dan serves as a Board Member at HealthEdge and MB Aerospace, and as a Board Observer at Precision Medicine Group. Previous experience includes roles as an Analyst in Private Equity at The Blackstone Group and in the Investment Banking Division at Goldman Sachs. Dan's educational background encompasses an MBA with Distinction from Harvard Business School, a BA in Economics with a Minor in Financial Mathematics from Dartmouth College, participation in an Economics Exchange Program at Università Bocconi, and a High School Diploma from Menlo School.